Amarin Corp Plc (AMRN)

[KCSVEN]

They have an outside chance but even if they beat the odds they are also 6-7 years minimum away from competing in best case scenario, so rather irrelevant. ACST was also, and science said they never had a chance but failing at this point is a bit surprising as they set a low bar.
Epanova failed as we all expected but removes a street overhang.

Amazing the overhangs the street puts on Amarin-ADCOM, FDA Approval, EPANOVA-all things on this board were easily dismissed as extremely low risk by common sense and good science. Next we have generic suit, already dismissed here by commons sense and great analysis but not on street. It pays to do a ton of due diligence. Though despite all the above the stock has not really gone anywhere since RI results but still, feels good to be smarter than the street!